Literature DB >> 29931797

Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia.

Scott K Ferguson1, Katherine Redinius1, Ayla Yalamanoglu2, Julie W Harral1, Jin Hyen Baek2, David Pak1, Zoe Loomis1, Daniel Hassell3, Paul Eigenberger1, Eva Nozik-Grayck1, Rachelle Nuss3, Kathryn Hassell3, Kurt R Stenmark1, Paul W Buehler2, David C Irwin1.   

Abstract

KEY POINTS: Sickle cell disease (SCD) results in cardiopulmonary dysfunction, which may be exacerbated by prolonged exposure to environmental hypoxia. It is currently unknown whether exposure to mild and moderate altitude exacerbates SCD associated cardiopulmonary and systemic complications. Three months of exposure to mild (1609 m) and moderate (2438 m) altitude increased rates of haemolysis and right ventricular systolic pressures in mice with SCD compared to healthy wild-type cohorts and SCD mice at sea level. The haemodynamic changes in SCD mice that had lived at mild and moderate altitude were accompanied by changes in the balance between pulmonary vascular endothelial nitric oxide synthase and endothelin receptor expression and impaired exercise tolerance. These data demonstrate that chronic altitude exposure exacerbates the complications associated with SCD and provides pertinent information for the clinical counselling of SCD patients. ABSTRACT: Exposure to high altitude worsens symptoms and crises in patients with sickle cell disease (SCD). However, it remains unclear whether prolonged exposure to low barometric pressures exacerbates SCD aetiologies or impairs quality of life. We tested the hypothesis that, relative to wild-type (WT) mice, Berkley sickle cell mice (BERK-SS) residing at sea level, mild (1609 m) and moderate (2438 m) altitude would have a higher rate of haemolysis, impaired cardiac function and reduced exercise tolerance, and that the level of altitude would worsen these decrements. Following 3 months of altitude exposure, right ventricular systolic pressure was measured (solid-state transducer). In addition, the adaptive balance between pulmonary vascular endothelial nitric oxide synthase and endothelin was assessed in lung tissue to determine differences in pulmonary vascular adaptation and the speed/duration relationship (critical speed) was used to evaluate treadmill exercise tolerance. At all altitudes, BERK-SS mice had a significantly lower percentage haemocrit and higher total bilirubin and free haemoglobin concentration (P < 0.05 for all). right ventricular systolic pressures in BERK-SS were higher than WT at moderate altitude and also compared to BERK-SS at sea level (P < 0.05, for both). Critical speed was significantly lower in BERK-SS at mild and moderate altitude (P < 0.05). BERK-SS demonstrated exacerbated SCD complications and reduced exercise capacity associated with an increase in altitude. These results suggest that exposure to mild and moderate altitude enhances the progression of SCD in BERK-SS mice compared to healthy WT cohorts and BERK-SS mice at sea level and provides crucial information for the clinical counselling of SCD patients.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  BERK mouse; critical speed; hemolysis; hypoxia

Mesh:

Substances:

Year:  2018        PMID: 29931797      PMCID: PMC6376072          DOI: 10.1113/JP275810

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  42 in total

1.  Population estimates of sickle cell disease in the U.S.

Authors:  Kathryn L Hassell
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition.

Authors:  Stephane L Bourque; Heather A Whittingham; Susan E Brien; Sandra T Davidge; Michael A Adams
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Skeletal Muscle Vascular Control During Exercise: Impact of Nitrite Infusion During Nitric Oxide Synthase Inhibition in Healthy Rats.

Authors:  Scott K Ferguson; Angela A Glean; Clark T Holdsworth; Jennifer L Wright; Alex J Fees; Trenton D Colburn; Thomas Stabler; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-08-12       Impact factor: 2.457

Review 4.  Cardiovascular complications and risk of death in sickle-cell disease.

Authors:  Mark T Gladwin
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

5.  Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology.

Authors:  David Grundy
Journal:  J Physiol       Date:  2015-06-15       Impact factor: 5.182

Review 6.  eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.

Authors:  Ruslan Rafikov; Fabio V Fonseca; Sanjiv Kumar; Daniel Pardo; Charles Darragh; Shawn Elms; David Fulton; Stephen M Black
Journal:  J Endocrinol       Date:  2011-06-03       Impact factor: 4.286

7.  Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Authors:  Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

8.  Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells.

Authors:  Chunying Li; Ling Ruan; Sarika G Sood; Andreas Papapetropoulos; David Fulton; Richard C Venema
Journal:  Vascul Pharmacol       Date:  2007-08-09       Impact factor: 5.773

9.  Methemoglobin is an endogenous toll-like receptor 4 ligand-relevance to subarachnoid hemorrhage.

Authors:  Min Seong Kwon; Seung Kyoon Woo; David B Kurland; Sung Hwan Yoon; Andre F Palmer; Uddyalok Banerjee; Sana Iqbal; Svetlana Ivanova; Volodymyr Gerzanich; J Marc Simard
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

10.  Guidelines for measuring cardiac physiology in mice.

Authors:  Merry L Lindsey; Zamaneh Kassiri; Jitka A I Virag; Lisandra E de Castro Brás; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733

View more
  5 in total

1.  Overview: pulmonary vascular function in health and disease.

Authors:  Larissa A Shimoda
Journal:  J Physiol       Date:  2019-02       Impact factor: 5.182

2.  The effect of dietary nitrate supplementation on the speed-duration relationship in mice with sickle cell disease.

Authors:  Scott K Ferguson; Katherine M Redinius; Julie W Harral; David I Pak; Delaney C Swindle; Daniel M Hirai; Jamie R Blackwell; Andrew M Jones; Kurt R Stenmark; Paul W Buehler; David C Irwin
Journal:  J Appl Physiol (1985)       Date:  2020-07-23

3.  Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study.

Authors:  Jose Enrique de la Rubia Ortí; Jose Luis Platero; María Benlloch; Lorena Franco-Martinez; Asta Tvarijonaviciute; Jesús Escribá-Alepuz; Sandra Sancho-Castillo
Journal:  Biomolecules       Date:  2021-04-21

4.  Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Scott K Ferguson; Susan M Majka; Vijaya Karoor; Radu Moldovan; Chantal Sintas; Jennifer Black; Thomas Gentinetta; Raphael M Buzzi; Florence Vallelian; Andreas Wassmer; Monika Edler; Joseph Bain; Daniel Schu; Kathryn Hassell; Rachelle Nuss; Dominik J Schaer; David C Irwin
Journal:  Free Radic Biol Med       Date:  2021-08-31       Impact factor: 8.101

5.  Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Mehdi A Fini; Kathryn Hassell; Rachelle Nuss; Rebecca B Wilkerson; Angelo D'Alessandro; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-07       Impact factor: 2.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.